Clinical Trial

A Study to Investigate the Efficacy and Safety of SC0032, a Magnesium Salt Oral Spray, in Adults With Refractory or Unexplained Chronic Cough

Study acronym: SensoryCloud
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a randomized placebo-controlled, parallel-arm study to determine the safety and efficacy of SC0032 in participants with RCC
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-01.
Trial Details
NCT Number NCT07690059
Lead Sponsor Sensory Cloud, Inc.
Conditions Refractory Chronic Cough and Unexplained Chronic Cough
Enrollment 60 participants
Start Date 2026-06-15
Primary Completion 2027-01 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-10